Proven Measured GFR for Preclinical Studies

  • Transdermal – No Sampling Required
  • Longitudinal Measurements Captured
  • Animal Not Restrained During Monitoring
  • Miniature Detection Device Used in All Animals
  • Validated Fluorescent Tracer Agents Employed
  • Over 150 Peer Reviewed Publications and Conference Abstracts

Optimized Design

  • Over 50% Smaller Device
  • Adjustable Sampling Rate
  • Robust Battery Interface
  • Reduced Motion Artifacts
  • Enhanced Data Precision
  • Supports Mac or PC


Successful Use in Nephrology Research

sellsheet_image1MediBeacon technology is used by leading medical schools, academic centers, research institutes, contract research organizations and pharmaceutical companies worldwide to enhance preclinical assessment of kidney therapeutics, evaluate nephrotoxicity, and gain fundamental understanding of kidney function in animals. Research using the MediBeacon preclinical product has been featured at scientific meetings worldwide. There are over 150 peer reviewed publications and conference abstracts in which this transdermal mGFR technique has been used.

(peer review and conference abstracts)


Preclinical Device – Technical Specifications

The instrument contains light emitting diodes which excite the fluorescent tracer agent and a photodiode that collects the light emission.

After amplification and digitization, the data sets are subsequently stored in the internal memory of the device. The data is transferred to a PC or Mac via USB connection. A basic software package is provided with the device. An advanced evaluation software product (Preclinical Data Studio) is sold separately.


MediBeacon Preclinical Transdermal GFR Monitor – Product Brochure – US (PDF) 

MediBeacon Preclinical Transdermal GFR Monitor – Product Brochure – A4 (PDF)

MediBeacon Terms and Conditions (PDF)

Contact Us

for more information on preclinical products.

This device is not approved for human use.